XML 61 R50.htm IDEA: XBRL DOCUMENT v3.24.3
Collaborative Agreements (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2020
Jan. 31, 2020
Aug. 31, 2019
Oct. 31, 2018
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Revenue from related parties         $ 0 $ 388,446 $ 100,762 $ 729,359
Advaccine | Collaborative Arrangement, Product                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Upfront payment received         0 1,200,000 0 3,600,000
ApolloBio | Collaborative Arrangement, Product                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Additional revenue to be achieved             $ 20,000,000.0  
Royalty period (in years)             10 years  
Revenue from related parties         0 238,000 $ 101,000 243,000
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Collaborative agreement, funding to be received $ 6,900,000              
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | Lassa Fever and MERS Vaccine                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Collaborative agreement, funding to be received             $ 56,000,000  
Collaborative agreement, period to receive funding for research and development (in years)             5 years  
Collaborative agreement, funding received         1,600,000 0 $ 1,600,000 1,800,000
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | INO-4800                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Collaborative agreement, funding to be received 1,300,000 $ 9,000,000.0            
Collaborative agreement, funding received         0 8,000 0 196,000
Coalition for Epidemic Preparedness Innovations | Collaborative Arrangement, Product | CELLECTRA 3PSP Proprietary Smart Device                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Collaborative agreement, funding to be received $ 5,000,000.0              
Bill and Melinda Gates Foundation | Collaborative Arrangement, Product | DNA-Encoded Monoclonal Antibody Technology                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Collaborative agreement, funding received     $ 1,100,000 $ 2,200,000 $ 0 $ 0 $ 39,000 $ 70,000